Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.23.1
Condensed Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 4,846 $ 12,068
Prepaid expenses and other current assets 1,015 1,149
Other receivables - related party 35 73
Total current assets 5,896 13,290
Total Assets 5,896 13,290
Current Liabilities:    
Accounts payable and accrued expenses 22,620 20,297
Accounts payable and accrued expenses - related party 1,851 1,306
Common stock warrant liabilities 3,604 11,170
Total current liabilities 28,075 32,773
Total Liabilities 28,075 32,773
Commitments and Contingencies
Stockholders' (Deficit) Equity    
Common stock issuable, 0 and 368,907 shares as of March 31, 2023 and December 31, 2022, respectively   1,885
Additional paid-in capital 250,780 241,117
Accumulated deficit (272,960) (262,486)
Total Stockholders' (Deficit) Equity (22,179) (19,483)
Total Liabilities and Stockholders' (Deficit) Equity 5,896 13,290
Common No Class    
Stockholders' (Deficit) Equity    
Common Stock Value $ 1 $ 1